160 related articles for article (PubMed ID: 34973844)
1. SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life.
Sponholtz SE; Ezendam NPM; de Rooij BH; Parner E; Mogensen O; Hildebrandt MG; Schledermann D; Markauskas A; Frøding LP; Fuglsang K; Bjørnholt SM; Jensen PT
Gynecol Oncol; 2022 Mar; 164(3):463-472. PubMed ID: 34973844
[TBL] [Abstract][Full Text] [Related]
2. The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer.
Bjørnholt SM; Sponholtz SE; Mogensen O; Bouchelouche K; Parner ET; Neumann G; Jochumsen KM; Hamid BH; Davidsen MB; Bjørn SF; Dahl K; Jensen PT
Gynecol Oncol; 2023 Apr; 171():121-128. PubMed ID: 36893488
[TBL] [Abstract][Full Text] [Related]
3. Does sentinel node mapping impact morbidity and quality of life in endometrial cancer?
Goncalves BT; Dos Reis R; Ribeiro R; Moretti-Marques R; Schamme FK; Oliveira GS; Tsunoda AT; Alvarenga-Bezerra V; Lopes A; Pastore CBP; Kumagai LY; Faloppa CC; Mantoan H; Badiglian-Filho L; De Brot L; Andrade CEMC; Baiocchi G
Int J Gynecol Cancer; 2023 Oct; 33(10):1548-1556. PubMed ID: 37699707
[TBL] [Abstract][Full Text] [Related]
4. Impact of comorbidities and extent of lymphadenectomy on quality of life in endometrial cancer patients treated with minimally invasive surgery in the era of sentinel lymph nodes.
Dinoi G; Multinu F; Yost K; AlHilli M; Larish A; Langstraat C; Kumar A; Weaver AL; McGree M; Cheville A; Dowdy S; Mariani A; Glaser G
Int J Gynecol Cancer; 2023 Aug; 33(8):1227-1236. PubMed ID: 37419517
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy.
Leitao MM; Zhou QC; Gomez-Hidalgo NR; Iasonos A; Baser R; Mezzancello M; Chang K; Ward J; Chi DS; Long Roche K; Sonoda Y; Brown CL; Mueller JJ; Gardner GJ; Jewell EL; Broach V; Zivanovic O; Dowdy SC; Mariani A; Abu-Rustum NR
Gynecol Oncol; 2020 Jan; 156(1):147-153. PubMed ID: 31780238
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter trial on sentinel lymph node biopsy in patients with early-stage cervical cancer (SENTIX).
Cibula D; Dusek J; Jarkovsky J; Dundr P; Querleu D; van der Zee A; Kucukmetin A; Kocian R
Int J Gynecol Cancer; 2019 Jan; 29(1):212-215. PubMed ID: 30640706
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer.
Niikura H; Okamoto S; Otsuki T; Yoshinaga K; Utsunomiya H; Nagase S; Takano T; Ito K; Watanabe M; Yaegashi N
Int J Gynecol Cancer; 2012 Sep; 22(7):1244-50. PubMed ID: 22864335
[TBL] [Abstract][Full Text] [Related]
10. Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology.
Cusimano MC; Walker R; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Murphy J; Rosen B; Covens A; Clarke B; Shaw P; Rouzbahman M; Mohan R; Ferguson SE
J Obstet Gynaecol Can; 2017 Aug; 39(8):659-667. PubMed ID: 28729099
[TBL] [Abstract][Full Text] [Related]
11. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
12. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping.
Schiavone MB; Scelzo C; Straight C; Zhou Q; Alektiar KM; Makker V; Soslow RA; Iasonos A; Leitao MM; Abu-Rustum NR
Ann Surg Oncol; 2017 Jul; 24(7):1965-1971. PubMed ID: 28258415
[TBL] [Abstract][Full Text] [Related]
13. Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
Mauro J; Viveros-Carreño D; Vizzielli G; De Ponti E; Fanfani F; Ramirez PT; Buda A
Int J Gynecol Cancer; 2023 Sep; 33(9):1370-1375. PubMed ID: 37586759
[TBL] [Abstract][Full Text] [Related]
14. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
[TBL] [Abstract][Full Text] [Related]
15. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
Lührs O; Ekdahl L; Geppert B; Lönnerfors C; Persson J
Gynecol Oncol; 2021 Nov; 163(2):289-293. PubMed ID: 34509298
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
17. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
[TBL] [Abstract][Full Text] [Related]
18. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymphatic mapping among women with early-stage cervical cancer: A systematic review.
Cheng-Yen Lai J; Lai KJ; Yi-Yung Yu E; Hung ST; Chu CY; Wang KL
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):636-643. PubMed ID: 30342642
[TBL] [Abstract][Full Text] [Related]
20. Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
Bizzarri N; Fedele C; Teodorico E; Certelli C; Pedone Anchora L; Carbone V; Giannarelli D; Fagotti A; Zannoni GF; Valente M; Querleu D; Ferrandina G; Scambia G; Fanfani F
Eur J Surg Oncol; 2024 Apr; 50(4):108250. PubMed ID: 38461568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
